| Animal models of nociception D Le Bars, M Gozariu, SW Cadden Pharmacological reviews 53 (4), 597-652, 2001 | 2844 | 2001 |
| EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis MA D’Agostino, P Conaghan, M Le Bars, G Baron, W Grassi, ... Annals of the rheumatic diseases 64 (12), 1703-1709, 2005 | 346 | 2005 |
| Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti … MC Genovese, M Schiff, M Luggen, JC Becker, R Aranda, J Teng, T Li, ... Annals of the rheumatic diseases 67 (4), 547-554, 2008 | 326 | 2008 |
| Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study PG Conaghan, MA D'Agostino, M Le Bars, G Baron, N Schmidely, ... Annals of the rheumatic diseases 69 (4), 644-647, 2010 | 242 | 2010 |
| The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched … M Schiff, C Pritchard, JE Huffstutter, V Rodriguez-Valverde, P Durez, ... Annals of the rheumatic diseases 68 (11), 1708-1714, 2009 | 206 | 2009 |
| Paracetamol in osteoarthritis of the knee C Miceli-Richard, M Le Bars, N Schmidely, M Dougados Annals of the rheumatic diseases 63 (8), 923-930, 2004 | 121 | 2004 |
| Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE … MA D'Agostino, RJ Wakefield, H Berner-Hammer, O Vittecoq, G Filippou, ... Annals of the rheumatic diseases 75 (10), 1763-1769, 2016 | 120* | 2016 |
| Temporal summation of C-fiber afferent inputs: competition between facilitatory and inhibitory effects on C-fiber reflex in the rat M Gozariu, D Bragard, JC Willer, D Le Bars Journal of neurophysiology 78 (6), 3165-3179, 1997 | 110 | 1997 |
| EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility P Conaghan, MA D’Agostino, P Ravaud, G Baron, M Le Bars, W Grassi, ... Annals of the rheumatic diseases 64 (12), 1710-1714, 2005 | 85 | 2005 |
| Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study MA d'Agostino, M Boers, RJ Wakefield, HB Hammer, O Vittecoq, ... RMD open 2 (1), e000237, 2016 | 82 | 2016 |
| Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial S Danese, S Vermeire, G d'Haens, J Panés, A Dignass, F Magro, M Nazar, ... The Lancet Gastroenterology & Hepatology 7 (4), 294-306, 2022 | 80 | 2022 |
| Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy MC Genovese, M Schiff, M Luggen, M Le Bars, R Aranda, A Elegbe, ... The Journal of rheumatology 39 (8), 1546-1554, 2012 | 72 | 2012 |
| An electrophysiological investigation into the monosynaptic H-reflex in the rat M Gozariu, V Roth, F Keime, D Le Bars, JC Willer Brain research 782 (1-2), 343-347, 1998 | 71 | 1998 |
| Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study M Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, ... Annals of the rheumatic diseases 70 (11), 2003-2007, 2011 | 67 | 2011 |
| Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET … PG Conaghan, P Durez, RE Alten, GR Burmester, PP Tak, L Klareskog, ... Annals of the rheumatic diseases 72 (8), 1287-1294, 2013 | 64 | 2013 |
| Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational … HG Nüßlein, R Alten, M Galeazzi, HM Lorenz, D Boumpas, ... BMC musculoskeletal disorders 15, 1-13, 2014 | 63 | 2014 |
| Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. B Bannwarth, F Pehourcq, F Lagrange, M Matoga, S Maury, M Palisson, ... The Journal of Rheumatology 28 (1), 182-184, 2001 | 59 | 2001 |
| Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study HG Nüßlein, R Alten, M Galeazzi, HM Lorenz, MT Nurmohamed, ... BMC Musculoskeletal Disorders 16, 1-11, 2015 | 54 | 2015 |
| Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries B Mazieres, N Scmidely, HJ Hauselmann, E Martin-Mola, U Serni, ... Annals of the rheumatic diseases 64 (8), 1158-1164, 2005 | 51 | 2005 |
| Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease T Kucharzik, R Wilkens, MA D’agostino, G Maconi, M Le Bars, M Lahaye, ... Clinical Gastroenterology and Hepatology 21 (1), 153-163. e12, 2023 | 49 | 2023 |
